These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 22720646)

  • 1. Bioanalysis Young Investigator: Omnia A Ismaiel.
    Ismaiel OA
    Bioanalysis; 2012 Jun; 4(11):1283-4. PubMed ID: 22720646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immunoaffinity purification and stable isotope dilution liquid chromatography/negative electrospray ionization tandem mass spectrometry.
    Oe T; Ackermann BL; Inoue K; Berna MJ; Garner CO; Gelfanova V; Dean RA; Siemers ER; Holtzman DM; Farlow MR; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(24):3723-35. PubMed ID: 17117458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.
    Dillen L; Cools W; Vereyken L; Timmerman P
    Bioanalysis; 2011 Jan; 3(1):45-55. PubMed ID: 21175366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioanalysis young investigator: Dajana Vuckovic.
    Vuckovic D
    Bioanalysis; 2012 Jun; 4(10):1155-7. PubMed ID: 22651558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of endogenous blood plasma phospholipids, cholesterol and glycerides that contribute to matrix effects in bioanalysis by liquid chromatography/mass spectrometry.
    Ismaiel OA; Zhang T; Jenkins RG; Karnes HT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(31):3303-16. PubMed ID: 21056019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitation of amyloid beta peptides Aβ(1-38), Aβ(1-40), and Aβ(1-42) in human cerebrospinal fluid by ultra-performance liquid chromatography-tandem mass spectrometry.
    Lame ME; Chambers EE; Blatnik M
    Anal Biochem; 2011 Dec; 419(2):133-9. PubMed ID: 21888888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid chromatography/tandem mass spectrometry characterization of oxidized amyloid beta peptides as potential biomarkers of Alzheimer's disease.
    Inoue K; Garner C; Ackermann BL; Oe T; Blair IA
    Rapid Commun Mass Spectrom; 2006; 20(5):911-8. PubMed ID: 16470704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioanalysis young investigator: Pan Deng.
    Deng P
    Bioanalysis; 2012 May; 4(9):997-8. PubMed ID: 22612679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses.
    Chambers E; Wagrowski-Diehl DM; Lu Z; Mazzeo JR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):22-34. PubMed ID: 17236825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ion suppression and enhancement effects of co-eluting analytes in multi-analyte approaches: systematic investigation using ultra-high-performance liquid chromatography/mass spectrometry with atmospheric-pressure chemical ionization or electrospray ionization.
    Remane D; Meyer MR; Wissenbach DK; Maurer HH
    Rapid Commun Mass Spectrom; 2010 Nov; 24(21):3103-8. PubMed ID: 20941756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC-MS/MS bioanalytical challenge: ultra-high sensitivity assays.
    Aubry AF
    Bioanalysis; 2011 Aug; 3(16):1819-25. PubMed ID: 21877891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An online nano-LC-ESI-FTICR-MS method for comprehensive characterization of endogenous fragments from amyloid β and amyloid precursor protein in human and cat cerebrospinal fluid.
    Brinkmalm G; Portelius E; Öhrfelt A; Mattsson N; Persson R; Gustavsson MK; Vite CH; Gobom J; Månsson JE; Nilsson J; Halim A; Larson G; Rüetschi U; Zetterberg H; Blennow K; Brinkmalm A
    J Mass Spectrom; 2012 May; 47(5):591-603. PubMed ID: 22576872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A broad-spectrum equine urine screening method for free and enzyme-hydrolysed conjugated drugs with ultra performance liquid chromatography/tandem mass spectrometry.
    Wong CH; Tang FP; Wan TS
    Anal Chim Acta; 2011 Jul; 697(1-2):48-60. PubMed ID: 21641418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipids in liquid chromatography/mass spectrometry bioanalysis: comparison of three tandem mass spectrometric techniques for monitoring plasma phospholipids, the effect of mobile phase composition on phospholipids elution and the association of phospholipids with matrix effects.
    Xia YQ; Jemal M
    Rapid Commun Mass Spectrom; 2009 Jul; 23(14):2125-38. PubMed ID: 19517478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of alkaloids in Coptis chinensis Franch by accelerated solvent extraction combined with ultra performance liquid chromatographic analysis with photodiode array and tandem mass spectrometry detections.
    Chen J; Wang F; Liu J; Lee FS; Wang X; Yang H
    Anal Chim Acta; 2008 Apr; 613(2):184-95. PubMed ID: 18395058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra-performance liquid chromatography/tandem mass spectrometric quantification of structurally diverse drug mixtures using an ESI-APCI multimode ionization source.
    Yu K; Di L; Kerns E; Li SQ; Alden P; Plumb RS
    Rapid Commun Mass Spectrom; 2007; 21(6):893-902. PubMed ID: 17295426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix effect elimination during LC-MS/MS bioanalytical method development.
    Côté C; Bergeron A; Mess JN; Furtado M; Garofolo F
    Bioanalysis; 2009 Oct; 1(7):1243-57. PubMed ID: 21083049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of urinary excretion of 1,N6-ethenoadenine, a potential biomarker of lipid peroxidation, in humans by stable isotope dilution liquid chromatography-electrospray ionization-tandem mass spectrometry: comparison with gas chromatography-mass spectrometry.
    Chen HJ; Chang CM
    Chem Res Toxicol; 2004 Jul; 17(7):963-71. PubMed ID: 15257622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying, evaluating, and controlling bioanalytical risks resulting from nonuniform matrix ion suppression/enhancement and nonlinear liquid chromatography-mass spectrometry assay response.
    Liu G; Ji QC; Arnold ME
    Anal Chem; 2010 Dec; 82(23):9671-7. PubMed ID: 21038862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted comparative proteomics by liquid chromatography/matrix-assisted laser desorption/ionization triple-quadrupole mass spectrometry.
    Melanson JE; Chisholm KA; Pinto DM
    Rapid Commun Mass Spectrom; 2006; 20(5):904-10. PubMed ID: 16470697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.